In December 2024, Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year. Year-on-year ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Meta's reversal of its content moderation efforts of the past few years is set to create a seismic shift within the social ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

NCC's responsibilities include site remediation, selective demolition, and the construction of a new extension at the site.

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...